Simple Summary In the past few years, the microbiota has emerged as a major player in
cancer management. The efficacy of chemotherapy or immunotherapy may be influenced by …

Lung cancer is still the leading cause of cancer death worldwide. Despite the major
diagnostic and therapeutic innovations, the effect on mortality has been modest and the …

Over the past decade, revolution in microbial research has provided valuable insights into
the function of microbes that inhabit human body. This complex community of microbes …

Giving the potential contribute in cancer initiation and progression, lung microbiota
represents a promising topic in cancer research, although still unexplored. We performed a …

Microbiota have emerged as key modulators of both the carcinogenic process and the
immune response against cancer cells, and, thus, it seems to influence the efficacy of …

The correlations between microbiota dysbiosis and cancer have gained extensive attention
and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a …

The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …

The microbiome of the lungs, although until recently neglected, is now emerging as a
potential contributor to chronic lung diseases, including cancer. Preclinical evidence …

Simple Summary Lung cancer is the major cause of cancer related deaths in the world. New
therapies have improved outcomes. Unfortunately, overall 5 year survival is~ 20 …

Over the last 10 years, with the development of culture-free bacterial identification
techniques, understanding of how the microbiome influences diseases has increased …